CS379491A3 - Compound, suitable for transdermal administration of dobutamine - Google Patents

Compound, suitable for transdermal administration of dobutamine Download PDF

Info

Publication number
CS379491A3
CS379491A3 CS913794A CS379491A CS379491A3 CS 379491 A3 CS379491 A3 CS 379491A3 CS 913794 A CS913794 A CS 913794A CS 379491 A CS379491 A CS 379491A CS 379491 A3 CS379491 A3 CS 379491A3
Authority
CS
Czechoslovakia
Prior art keywords
dobutamine
alkyl
pharmaceutically acceptable
skin
acceptable salt
Prior art date
Application number
CS913794A
Other languages
Czech (cs)
English (en)
Inventor
Himatlal Valia Kirti
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS379491A3 publication Critical patent/CS379491A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS913794A 1990-12-20 1991-12-13 Compound, suitable for transdermal administration of dobutamine CS379491A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63048090A 1990-12-20 1990-12-20

Publications (1)

Publication Number Publication Date
CS379491A3 true CS379491A3 (en) 1992-07-15

Family

ID=24527346

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913794A CS379491A3 (en) 1990-12-20 1991-12-13 Compound, suitable for transdermal administration of dobutamine

Country Status (12)

Country Link
EP (1) EP0492930A3 (pt)
JP (1) JPH04275219A (pt)
KR (1) KR920011479A (pt)
AU (1) AU8985791A (pt)
BR (1) BR9105371A (pt)
CA (1) CA2057647A1 (pt)
CS (1) CS379491A3 (pt)
HU (1) HU914012D0 (pt)
IE (1) IE914453A1 (pt)
IL (1) IL100367A0 (pt)
MX (1) MX9102627A (pt)
ZA (1) ZA919853B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101526781B1 (ko) * 2011-02-15 2015-06-05 일라이 릴리 앤드 캄파니 펜타닐의 경피 용액을 사용하여 개에서 통증을 제어하는 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4704407A (en) * 1984-12-20 1987-11-03 Eli Lilly And Company Soluble dobutamine salts
ATE77962T1 (de) * 1985-02-25 1992-07-15 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤
US4814173A (en) * 1987-09-08 1989-03-21 Warner-Lambert Company Silicone elastomer transdermal matrix system

Also Published As

Publication number Publication date
MX9102627A (es) 1992-06-01
IE914453A1 (en) 1992-07-01
JPH04275219A (ja) 1992-09-30
EP0492930A2 (en) 1992-07-01
EP0492930A3 (en) 1992-10-14
HU914012D0 (en) 1992-03-30
CA2057647A1 (en) 1992-06-21
BR9105371A (pt) 1992-08-25
KR920011479A (ko) 1992-07-24
AU8985791A (en) 1992-06-25
IL100367A0 (en) 1992-09-06
ZA919853B (en) 1993-06-14

Similar Documents

Publication Publication Date Title
KR101342357B1 (ko) 개선된 테스토스테론 겔 및 사용 방법
KR101173159B1 (ko) 알칼로이드 제형
KR960005705B1 (ko) 플로르페니콜의 약제학적 조성물
CA2463896C (en) Injectable compositions for the controlled delivery of pharmacologically active compound
US20070077288A1 (en) Transdermal delivery of non-steroidal anti-inflammatory drugs
US9649364B2 (en) Methods for producing stable therapeutic formulations in aprotic polar solvents
KR101651448B1 (ko) 체지방을 국소적으로 증가시키는 방법 및 조성물
NL8403618A (nl) Werkwijze voor het percutaan toedienen van metoclopramide.
HU229205B1 (en) Use of biguanide derivatives for preparation of medicament having a wound healing effect
TW201247218A (en) Suspension type topical formulations comprising cyclic depsipeptide
JP2022500362A (ja) 新規組成物および方法
BRPI0720102A2 (pt) Formulação de deposição
CN111295202B (zh) 治疗甲癣的外用制剂
CA2814696A1 (en) Pharmaceutical formulation for histone deacetylase inhibitors
US20210059967A1 (en) Liquid parenteral compositions of levothyroxine
MXPA05008596A (es) Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol.
CS379491A3 (en) Compound, suitable for transdermal administration of dobutamine
BR0308874B1 (pt) Solução injetável estável em temperatura ambiente para uso veterinário, e método para produzir a mesma
HU196307B (en) Process for producing vermicides comprising levamisole-nitroxinil salt
KR102466251B1 (ko) 뇌소혈관 질환 치료용 약물 제조에서의 화합물의 응용
JP6625208B2 (ja) 経皮製剤
RU2618462C2 (ru) Способ и улучшенная фармацевтическая композиция для ускорения трансдермальной доставки ингибитора pde-5
EP4389147A2 (en) Therapeutic formulations and uses thereof
CA2453993A1 (en) Method and composition for treatment of cancer
US20190091168A1 (en) Formulation for enhanced transdermal absorption of drug